Literature DB >> 22885365

A population-based cross-sectional study of cardiovascular risk factor in Latvia.

Andrejs Ērglis1, Vilnis Dzērve, Jeļena Pahomova-Strautiņa, Inga Narbute, Sanda Jēgere, Iveta Mintāle, Renāte Ligere, Pēteris Apinis, Aivars Lejnieks, Dana Misiņa, Aldis Rozenbergs.   

Abstract

BACKGROUND AND
OBJECTIVE: To date, the epidemiological studies of noncommunicable diseases in Latvia were more episodic and covered only selected areas. The first national cross-sectional population-based survey of cardiovascular risk factors after regaining independence was carried out to provide reliable information on the cardiovascular risk factor profile in adults.
MATERIAL AND METHODS: Computerized random sampling from the Registry of Latvian population was carried out. A total of 6000 enrolled subjects aged 25-74 years were divided into 10 age subgroups. The data of 3807 respondents (63.5% of all) were included into the final analysis.
RESULTS: The mean number of cardiovascular risk factors was 2.99±0.026 per subject: 3.45±0.043 and 2.72±0.030 for men and women, respectively. Of all the respondents, 75.2% had an increased total cholesterol level. Hypercholesterolemia was found in almost 56% of men and 41% of women in the age group of 25-34 years. Hyperglycemia was documented in 34.1% of the respondents (41.6% of men and 29.8% of women). More than two-thirds (67.8%) of the persons were overweight, while obesity was found in 25.6% of men and 32.6% of women. Arterial hypertension was identified in 44.8% of the respondents; its prevalence was higher in men than women (52.9% vs. 40.2%). There were more current smokers among men than women (30.5% vs. 11.4%).
CONCLUSIONS: The levels of cardiovascular risk factors in Latvia were found to be relatively high. The data can be utilized as baseline characteristics that can be compared down the road including the monitoring of health prevention activities.

Entities:  

Mesh:

Year:  2012        PMID: 22885365

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  6 in total

1.  Prevalence estimation of celiac disease in the general adult population of Latvia using serology and HLA genotyping.

Authors:  Marcis Leja; Zakera Shums; Liene Nikitina-Zake; Mikus Gavars; Ilze Kikuste; Jay Milo; Ilva Daugule; Jelena Pahomova; Valdis Pirags; Vilnis Dzerve; Janis Klovins; Andrejs Erglis; Gary L Norman
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

2.  Comparative Analysis of the Most Important Cardiovascular Risk Factors Based on Cross-Sectional Studies in the Population of Latvia.

Authors:  Andrejs Erglis; Iveta Bajare; Sanda Jegere; Iveta Mintale; Juris Barzdins; Artis Luguzis; Peteris Apinis; Anda Caksa; Iveta Gavare; Vilnis Dzerve
Journal:  Medicina (Kaunas)       Date:  2022-05-06       Impact factor: 2.948

3.  Association of depression and anxiety with cardiovascular co-morbidity in a primary care population in Latvia: a cross-sectional study.

Authors:  R Ivanovs; A Kivite; D Ziedonis; I Mintale; J Vrublevska; E Rancans
Journal:  BMC Public Health       Date:  2018-03-06       Impact factor: 3.295

4.  Genome Database of the Latvian Population (LGDB): Design, Goals, and Primary Results.

Authors:  Vita Rovite; Yael Wolff-Sagi; Linda Zaharenko; Liene Nikitina-Zake; Elmars Grens; Janis Klovins
Journal:  J Epidemiol       Date:  2018-03-24       Impact factor: 3.211

5.  Excess Cardiovascular Mortality in Latvia: A Novel Approach Based on Patient-Level Data to Estimate the Separate Contributions of Primary Prevention, Accessibility and Quality of Hospital Care.

Authors:  Jacopo Lenzi; Chiara Reno; Jolanta Skrule; Jana Lepiksone; Ģirts Briģis; Alina Dūdele; Maria Pia Fantini
Journal:  Int J Health Policy Manag       Date:  2022-06-01

6.  Obesity, high-molecular-weight (HMW) adiponectin, and metabolic risk factors: prevalence and gender-specific associations in Estonia.

Authors:  Triin Eglit; Inge Ringmets; Margus Lember
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.